SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-076394
Filing Date
2021-06-03
Accepted
2021-06-03 16:22:04
Documents
15
Period of Report
2021-05-27
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2118332d1_8k.htm   iXBRL 8-K 31682
2 EXHIBIT 99.1 tm2118332d1_ex99-1.htm EX-99.1 14530
7 GRAPHIC tm2118332d1_ex99-1img001.jpg GRAPHIC 5694
  Complete submission text file 0001104659-21-076394.txt   284832

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abt-20210527.xsd EX-101.SCH 3546
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abt-20210527_def.xml EX-101.DEF 28692
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abt-20210527_lab.xml EX-101.LAB 37876
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abt-20210527_pre.xml EX-101.PRE 26911
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2118332d1_8k_htm.xml XML 5466
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 21992777
SIC: 2834 Pharmaceutical Preparations